Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Invested Capital (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Invested Capital data on record, last reported at -$33.9 million in Q4 2025.

  • For Q4 2025, Invested Capital fell 788.74% year-over-year to -$33.9 million; the TTM value through Dec 2025 reached -$33.9 million, down 788.74%, while the annual FY2025 figure was -$33.9 million, 788.74% down from the prior year.
  • Invested Capital reached -$33.9 million in Q4 2025 per TLSI's latest filing, down from $6.0 million in the prior quarter.
  • Across five years, Invested Capital topped out at $12.9 million in Q2 2025 and bottomed at -$188.4 million in Q2 2023.
  • Average Invested Capital over 4 years is -$66.1 million, with a median of -$30.5 million recorded in 2023.
  • The widest YoY moves for Invested Capital: up 423.13% in 2025, down 788.74% in 2025.
  • A 4-year view of Invested Capital shows it stood at -$172.4 million in 2022, then soared by 84.3% to -$27.1 million in 2023, then soared by 85.92% to -$3.8 million in 2024, then plummeted by 788.74% to -$33.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were -$33.9 million in Q4 2025, $6.0 million in Q3 2025, and $12.9 million in Q2 2025.